Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

October 31, 2008

Conditions
Mild NephropathyModerate NephropathyDiabetes Mellitus
Interventions
DRUG

Technosphere Inhalation Powder

Technosphere Inhalation Powder

Trial Locations (3)

55404

Davita Clinical Research, Minneapolis

68154

Qualia Clinical Research, Omaha

78229

Diabetes & Glandular Disease Research Assoc PA, San Antonio

Sponsors
All Listed Sponsors
lead

Mannkind Corporation

INDUSTRY